FIGURE

Fig. 3

ID

ZDB-FIG-260430-31

Publication

Baek et al., 2026 - A novel small molecule KMU-11361 attenuates rheumatoid arthritis by mechanistic inhibition of the TAK1-NF-κB-NLRP3 axis

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Synthesis of KMU-11361 and its binding properties to the inflammatory kinases TAK1 and MAPK1. A Chemical structure of KMU-11361. B Kinase inhibitory activity and selectivity profile of KMU-11361 against inflammation-related kinases, as determined by kinase assay. C Bar chart of the top enriched terms from the KEGG_2021_Human gene set library. The top 10 enriched terms for the input gene set are displayed based on the −log10 (p value). The term at the top has the most significant overlap with the input query gene set. Colored bars correspond to the terms with significant p values (< 0.05). Two potential binding conformations of KMU-11361 with the MAPK1 and TAK1 proteins are illustrated, based on the binding orientation of the reference compound SU6668. D–G Docking simulation results of KMU-11361 with MAPK1 and TAK1. The D and E panels depict binding poses of KMU-11361 with MAPK1 which share the same binding direction but appear as flipped versions of each other. In conformation, D KMU-11361 interacts with LYS112, MET106, ASP104, and LYS52. In conformation, E the flipped pose engages LYS114, ASP111, MET108, and ASP106. The f and g panels depict the binding poses of KMU-11361 with TAK1 which also share the same binding direction but are flipped relative to each other. In conformation, F KMU-11361 interacts with TYR106 and ASP175, while in conformation [1], G the flipped pose engages GLU77 and ASP175. The protein structures of MAPK1 and TAK1 presented here correspond to the PDB entries 5BUJ, 6G9A, 5JGA, and 4O91, respectively. H macrophage-like THP-1 and human RA-FLS cells were stimulated with LPS (1 µg/mL) for the designated time points and treated with varying concentrations of KMU-11361. Whole cell lysates were isolated and analyzed for TAK1 and MAPK1 protein expression levels using western blot analysis. Jurkat T cells were activated with anti-CD3/CD28 for the designated time points and treated with varying concentrations of KMU-11361. Whole cell lysates were isolated and analyzed for TAK1 and MAPK1 protein expression levels using western blot analysis. The expression level of β-actin protein was used as the loading control

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Inflamm. Res.